SAmple 3
docx
keyboard_arrow_up
School
San Jose State University *
*We aren’t endorsed by this school
Course
7032
Subject
Medicine
Date
Nov 24, 2024
Type
docx
Pages
10
Uploaded by AdmiralTitanium1237
“
Investigating the Effectiveness of Cross-Sector Collaborations in Pharmaceutical
Innovation in Ireland”
Slide 1: In the pharmaceutical industry, cross-sector collaboration is a dynamic and cutting-edge strategy
that brings together stakeholders from several industries to address healthcare concerns and
foster innovation. Collaborations between pharmaceutical firms, academic institutions,
governmental bodies, healthcare practitioners, patient advocacy groups, and other significant
parties are all included in this collaborative paradigm (Awad, 2023). The intention is to enhance
patient outcomes by leveraging the distinctive knowledge, resources, and views of each sector
while also fostering collaboration and bolstering research capacity. Cross-sector coalitions
present a special chance to combine various viewpoints, abilities, and resources to successfully
address these issues (Callejas Carrión, and Flynn, 2023). Understanding these collaborations'
efficacy in Ireland with the aim of improving patient care and healthcare outcomes is the focus of
this study. As a result, other nations' scientists, CEOs, and politicians can profit from
understanding Ireland's experience with cross-sector relationships.
Slide 2:
1.
To identify if companies in Ireland is welcoming cross-sector collaboration or not.
2.
Conduct interviews with pharmaceutical industry professionals such as project managers (R&D professionals, regulatory professionals etc), team leaders, professors, health care professionals etc. to learn about their experiences and opinions on cross-sector cooperation.
3.
To identify the major players participating in cross-sector pharmaceutical innovation collaborations in Ireland.
4.
To identify the role of digital technologies in Pharmaceutical Innovations.
Slide 3:
Through the analysis of the literature, it is clear that collaborations are essential in the
pharmaceutical industry because they foster creativity, quicken R&D, and improve patient
outcomes (Ganotice et al., 2023). Teamwork is an essential component strategy due to the
difficulties and high costs associated with medication research, clinical trials, and regulatory
processes. Working with educational institutions, research teams, and technical enterprises gives
pharmaceutical companies access to a variety of expertise, resources, and technologies.
According to Björlekvist, and Ly, (2023), partnerships enable the sharing of risks, costs, and
regulatory burdens, hastening the development and marketing of novel medicines. Collaborations
in the pharmaceutical industry lead to ground-breaking discoveries, promote multidisciplinary
approaches, and more effectively address complicated healthcare issues, ultimately benefiting
patients and advancing the medical profession.
Slide 4:
Based on several of variables, pharmaceutical businesses in Ireland may or may not be open to
working with other industries. Depending on their unique aims, ambitions, and internal
resources, different organizations may be more or less eager to collaborate than others. R&D,
innovation, and growing their product pipelines are priorities for businesses, and these businesses
are more likely to cooperate (Callejas Carrión, and Flynn, 2023). Collaborations allow
organizations to access outside knowledge, make use of complementary resources, and hasten
the development of novel technology or medical processes. As a case study, the cross-sector
partnership between Pfizer and BioNTech in the creation and distribution of the COVID-19
vaccine is a brilliant illustration of successful partnership (Bright, 2023). The partnership
combined the cutting-edge mRNA technology of BioNTech with the pharmacological expertise
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
and global production network of Pfizer to produce amazing results. They efficiently navigated
the regulatory approval procedure, made the most of their industrial potential, and set up a global
supply network for fair distribution. The partnership resulted in the invention of a very effective
and protected vaccination that will play a vital role in limiting the COVID-19 pandemic
worldwide (Filiou, 2023). This alliance creates a template for future collaborations between the
pharmaceutical industry and other sectors to address urgent public health issues. In order to
ensure the product's efficiency, performance, and assurance, the government has put tight legal
constraints on the manufacture of pharmaceutical items. The pharmaceutical sector is subject to
strict regulation (Dzhengiz, and Patala, 2023). Cross-sector collaboration may become more
difficult as a result of the necessity for the various stakeholders to adhere to various standards.
Slide 5:
Slide 6:
Through the use of the qualitative audio recording technique, the interpretivism philosophy has
been incorporated into the method by highlighting the significance of individual perspectives and
experiences in influencing the study results. A qualitative research methodology was used in the
investigation (Ganotice et al., 2023). Understanding people's actual experiences is the goal of this
qualitative research technique. The study conducted interview using audio recordings to collect
data for the project, which is set up as a qualitative study. To obtain information about the
participants' experiences with cross-sector collaboration, the challenges they have faced, and the
benefits they have seen with the adoption of qualitative strategy, semi-structured interviews have
been conducted. The study was conducted using a two-phased approach. The first step involved
conducting the interviews and analyzing the data (Hoey et al., 2022). The second phase properly
presented the transcription of the research's findings. The qualitative audio recordings were
analyzed using an inductive method, allowing for the emergence of themes and patterns directly
from the content itself without the use of pre-established categories or presumptions.
Slide 7:
Interviews were used as the primary method of data collection at the start of the project. It was
carried out in collaboration with a variety of stakeholders, including leaders from industry,
academia, the government, and patient advocacy groups who were engaged in cross-sector
cooperation in Irish pharmaceutical innovation (Kinchin et al., 2023). In order to learn about the
participants' experiences with cross-sector collaboration, the challenges they have faced, and the
benefits they have noticed, semi-structured interviews (audio recording collection) were done
(Björlekvist, and Ly, 2022). The themes that emerge from the interview has been used, and audio
recordings provided by the professionals re collected and transcribed, in order to gain a better
understanding of the effectiveness of cross-sector cooperation in pharmaceutical innovation in
Ireland. The data would next be examined using thematic analysis (Kirkland, 2023). In the study,
a purposeful sample approach was adopted, and all six professionals took part in one or two
cross-sector collaborations either directly or indirectly.
Slide 8:
Respondents
Responses
Can you describe your experience with cross-
sector collaborations in the pharmaceutical
industry in Ireland? Specifically, what
collaborations have your company been
involved in and what was you or your
company’s role?
“
I have always experienced the cross sector
collaboration in pharmaceutical companies
that I’ve worked in different pharmaceuticals
in MSD, Brystol Myers and Viatris, there is a
cross sector collaboration”.
How receptive do you think companies in
Ireland are to cross-sector collaborations in
pharmaceutical innovation? What factors
influence their willingness to engage in such
collaborations?
Cross sector colllaborations are good and
Ireland is very much receptive for cross sector
collaboration because of lack of skills, lack of
resource, lack of knowledge, so they need to
hire from outside to run their business
”.
Can you provide examples of major players or
organizations that are actively participating in
cross-sector
pharmaceutical
innovation
collaborations in Ireland? How have these
collaborations impacted the industry?
“These collaborations have had a significant
impact on the Irish pharmaceutical industry.
They have helped to attract new investment,
create jobs, and develop new drugs and
treatments.”
Slide 9:
The cross-sector partnerships are probably going to help speed up the development of novel
therapies and medications while also improving patient care within pharmaceutical firms.
However, research based on the responses suggest that a variety of factors, including the
possibility of financial rewards, access to new information or technologies, and the desire for
improved outcomes for patients, influence the inclination to engage in cross-sector
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
collaborations. The results from the findings show that a variety of factors, such as the possibility
to hasten the discovery of new treatments and pharmaceuticals and the potential for financial and
commercial beliefs, impact the readiness of the pharmaceutical companies to participate in such
coalitions.
Slide 10:
According to the findings, cross-sector collaboration is essential for innovation in Ireland's
pharmaceutical industry. The success of this relationship is significantly influenced by factors
such as culture, financial strategies, intellectual property rights, legal frameworks, and
knowledge-sharing policies. Leadership plays a crucial role in helping organizations reach shared
goals and making wise decisions. Transparent communication helps close gaps, and trust
guarantees that agreements are kept (Awad, 2023). There are several opportunities for
accelerating knowledge transfer and decision-making with AI and big data analytics. However,
difficulties continue, such as data protection and expertise needs. Working alone is less effective
in fostering creativity and achieving solid results than working together to aggregate diverse
knowledge and resources (Provenzano, 2023).
Slide 11:
As the research continued, it became abundantly evident that cross-sector collaboration offers a
great deal of potential to encourage creativity by fusing various skills, resources, and
perspectives. The findings highlighted how these collaborations could speed up the discovery,
development, and commercialization of new drugs, potentially leading to superior patient
outcomes and more effective healthcare solutions. The wide exchange of knowledge and
resources across industries can create innovations that would otherwise remain unreachable
without collaboration. The study also identified challenges that must be surmounted if these
connections are to succeed to their full potential. A number of issues, including as concerns about
intellectual property, competing goals, poor communication, and regulatory obstacles may make
it difficult to integrate operations smoothly.
Slide 12:
It might be suggested that establishing clear and effective channels of communication among
cross-sector partners is crucial. The pharmaceutical sector should focus on frequent updates,
open communication, and pro-active feedback loops that aid in understanding and goal
alignment. By coordinating, it is possible to avoid misunderstandings and discrepancies in
expectations.
References Awad, M.H., 2023. Place and the structuring of cross-sector partnerships: The moral and material
conflicts over healthcare and homelessness. Journal of Business Ethics, 184(4), pp.933-955.
Björlekvist, J.H. and Ly, T.P.D., 2022. Decarbonization and Cross-sector partnership: A case
study of Energize in the pharmaceutical industry.
Bright, A., 2023. UKI PRME Conference 2023 UK and Ireland PRME Chapter's 10th
Anniversary Conference. Image, 27, p.28.
Callejas Carrión, Z. and Flynn, T., 2023. Cancer Survivorship and AI for Well-being White
Paper: A European research projects collaborative perspective.
Dzhengiz, T. and Patala, S., 2023. The role of cross
‐
sector partnerships in the dynamics between
places and innovation ecosystems. R&D Management.
Filiou, D.D. (2023) ‘The Pfizer-BioNTech Vaccine: Openness and Collaboration to Tackle the
World’s Problems’. Available at: https://business-school.open.ac.uk/news/pfizer-biontech-
vaccine-openness-and-collaboration-tackle-world%E2%80%99s-problems.
Ganotice Jr, F., Zheng, B., Ng, P.Y., Leung, S.C., Barrett, E.A., Chan, H.Y.C., Chan, C.W., Chan,
K.W.S., Chan, L., Chan, M.K. and Chan, S.L.P., 2023. Towards a global partnership model in
interprofessional education for cross-sector problem-solving. BMC Medical Education, 23(1),
p.457.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
Hardy, C., Lawrence, T.B. and Phillips, N. (2006) ‘Swimming with Sharks: Creating Strategic
Change through Multi-Sector Collaboration’. International Journal of Strategic Change
Management, 1(1/2), p. 96. DOI: 10.1504/IJSCM.2006.011105.
Hoey, R., Sharpe, E., Kukula, A. and Workman, P., 2022. Enhancing access to innovative cancer
drugs: Cross-sector consensus on a way forward to benefit patients. Drug Discovery
Today
, 27
(4), pp.946-950.
Kinchin, I., Walshe, V., Normand, C., Coast, J., Elliott, R., Kroll, T., Kinghorn, P., Thompson, A.,
Viney, R., Currow, D. and O’Mahony, J.F., 2023. Expanding health technology assessment
towards broader value: Ireland as a case study. International Journal of Technology Assessment
in Health Care, 39(1), p.e26.
Kirkland, C., 2023. Cross-Sectional Collaboration in Florida's Emergency Management System
(Doctoral dissertation, Walden University).
Kohtamäki, M., Rabetino, R. and Huikkola, T., 2023. Learning in strategic alliances: Reviewing
the literature streams and crafting the agenda for future research. Industrial Marketing
Management, 110, pp.68-84.
Provenzano, A.M., 2023. Cross-Sector Care Activities and Technological Capabilities of
Federally Qualified Health Centers in Michigan (Doctoral dissertation, University of Michigan).